LOSS OF RESPONSE AND DOSE ESCALATION OF INFLIXIMAB AND ADALIMUMAB IN ULCERATIVE COLITIS PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Edo Savelkoul  1     Pepijn Thomas  1     Lauranne Derikx  1     Nathan Den Broeder  1     Tessa E.H. Römkens  2     Frank Hoentjen  3    
1 Radboudumc, Nijmegen, Netherlands
2 Jeroen Bosch Hospital, Den Bosch, Netherlands
3 University of Alberta, Edmonton, Canada

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing